95 related articles for article (PubMed ID: 35038209)
1. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
[TBL] [Abstract][Full Text] [Related]
2. Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study.
Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Dhamne C; Blair S; Lam C; Rujkijyanont P; Traivaree C; Photia A; Veerapan P; Puhaindran ME; Oh BLZ; Wang E; Rodriguez-Galindo C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):631-640. PubMed ID: 35225476
[TBL] [Abstract][Full Text] [Related]
3. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
4. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.
Friedrich P; Ortiz R; Strait K; Fuentes S; Gamboa Y; Arambú I; Ah-Chu-Sanchez M; London W; Rodríguez-Galindo C; Antillón-Klussmann F; Báez F;
Cancer; 2013 Feb; 119(4):871-9. PubMed ID: 22972687
[TBL] [Abstract][Full Text] [Related]
5. The Effect of a Patient Navigator on Treatment Abandonment and Follow-up for High Grade Osteosarcoma Patients in the Philippine General Hospital.
Gaston CL; Taleon K; Barsales K; Dimayuga C; Estanislao J; Fajardo P; Quintos A; Rubio D; Wang E; Alcasabas AP
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2873-2877. PubMed ID: 34582656
[TBL] [Abstract][Full Text] [Related]
6. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala.
Alvarez E; Seppa M; Rivas S; Fuentes L; Valverde P; Antillón-Klussmann F; Castellanos M; Sweet-Cordero EA; Messacar K; Kurap J; Bustamante M; Howard SC; Efron B; Luna-Fineman S
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423236
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Choeyprasert W; Natesirinilkul R; Charoenkwan P; Sittipreechacharn S
Asian Pac J Cancer Prev; 2013; 14(2):1101-6. PubMed ID: 23621194
[TBL] [Abstract][Full Text] [Related]
9. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru.
Vasquez L; Diaz R; Chavez S; Tarrillo F; Maza I; Hernandez E; Oscanoa M; García J; Geronimo J; Rossell N
Pediatr Blood Cancer; 2018 Jun; 65(6):e27007. PubMed ID: 29431252
[TBL] [Abstract][Full Text] [Related]
11. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
12. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
13. Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes?
Friedrich P; Ortiz R; Fuentes S; Gamboa Y; Ah Chu-Sanchez MS; Arambú IC; Montero M; Báez F; Rodríguez-Galindo C; Antillón-Klussmann F;
Cancer; 2014 Jan; 120(1):112-25. PubMed ID: 24132910
[TBL] [Abstract][Full Text] [Related]
14. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: A step towards better focussed counselling.
Alam A; Kumar A
Cancer Epidemiol; 2018 Dec; 57():53-59. PubMed ID: 30316108
[TBL] [Abstract][Full Text] [Related]
17. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
18. Preventing treatment abandonment for children with solid tumors: A single-center experience in Brazil.
Ferman S; Lima FFDS; Lage CRS; da Hora SS; Vianna DT; Thuler LC
Pediatr Blood Cancer; 2019 Jul; 66(7):e27724. PubMed ID: 30938082
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
Sofulu Ö; Erol B
Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
[TBL] [Abstract][Full Text] [Related]
20. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I
J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
